NeuroOne Medical Technologies Files 8-K
Ticker: NMTC · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1500198
| Field | Detail |
|---|---|
| Company | Neuroone Medical Technologies CORP (NMTC) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
TL;DR
NeuroOne Medical Technologies filed an 8-K on Jan 10, 2025, detailing financial and operational results.
AI Summary
NeuroOne Medical Technologies Corp. filed an 8-K on January 10, 2025, reporting on its results of operations and financial condition. The filing also includes information on Regulation FD disclosures and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located in Eden Prairie, MN.
Why It Matters
This 8-K filing provides an update on NeuroOne Medical Technologies' financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing providing operational and financial updates, not indicating any immediate or significant risks.
Key Players & Entities
- NeuroOne Medical Technologies Corp. (company) — Registrant
- January 10, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Eden Prairie, MN (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on NeuroOne Medical Technologies Corp.'s results of operations and financial condition, as well as to provide Regulation FD disclosures and financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on January 10, 2025.
Where are NeuroOne Medical Technologies Corp.'s principal executive offices located?
NeuroOne Medical Technologies Corp.'s principal executive offices are located at 7599 Anagram Dr., Eden Prairie, MN 55344.
In which state was NeuroOne Medical Technologies Corp. incorporated?
NeuroOne Medical Technologies Corp. was incorporated in Delaware.
What is the IRS Employer Identification Number for NeuroOne Medical Technologies Corp.?
The IRS Employer Identification Number for NeuroOne Medical Technologies Corp. is 27-0863354.
Filing Stats: 766 words · 3 min read · ~3 pages · Grade level 11.9 · Accepted 2025-01-10 09:00:40
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share NMTC The Nasdaq Stock Mar
Filing Documents
- ea0225131-8k_neuroone.htm (8-K) — 27KB
- ea022513101ex99-1_neuroone.htm (EX-99.1) — 15KB
- ea022513101ex99-2_neuroone.htm (EX-99.2) — 23KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- ex99-2_001.jpg (GRAPHIC) — 100KB
- ex99-2_002.jpg (GRAPHIC) — 454KB
- ex99-2_003.jpg (GRAPHIC) — 230KB
- ex99-2_004.jpg (GRAPHIC) — 276KB
- ex99-2_005.jpg (GRAPHIC) — 283KB
- ex99-2_006.jpg (GRAPHIC) — 235KB
- ex99-2_007.jpg (GRAPHIC) — 174KB
- ex99-2_008.jpg (GRAPHIC) — 73KB
- ex99-2_009.jpg (GRAPHIC) — 214KB
- ex99-2_010.jpg (GRAPHIC) — 201KB
- ex99-2_011.jpg (GRAPHIC) — 227KB
- ex99-2_012.jpg (GRAPHIC) — 227KB
- ex99-2_013.jpg (GRAPHIC) — 237KB
- ex99-2_014.jpg (GRAPHIC) — 203KB
- ex99-2_015.jpg (GRAPHIC) — 175KB
- ex99-2_016.jpg (GRAPHIC) — 258KB
- ex99-2_017.jpg (GRAPHIC) — 190KB
- ex99-2_018.jpg (GRAPHIC) — 207KB
- ex99-2_019.jpg (GRAPHIC) — 101KB
- 0001213900-25-002381.txt ( ) — 5846KB
- nmtc-20250110.xsd (EX-101.SCH) — 3KB
- nmtc-20250110_lab.xml (EX-101.LAB) — 33KB
- nmtc-20250110_pre.xml (EX-101.PRE) — 22KB
- ea0225131-8k_neuroone_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On January 10, 2025, the Company posted an updated corporate presentation to its website at https://nmtc1.com/investors, which the Company may use from time to time in communications or conferences. A copy of the corporate presentation is attached as Exhibit 99.2 to this Current Report on Form 8-K. The information in this Item 7.01 (including the exhibit hereto) is furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing. This Item 7.01 and Exhibit 99.2 hereto contain forward-looking not guarantees of future performance. Further, the forward-looking statements are subject to the limitations listed in Exhibit 99.2 and in the other reports of the Company filed with the Securities and Exchange Commission, including that actual events or results may differ materially from those in the forward-looking statements.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release, dated January 10, 2025 99.2 Corporate Presentation, dated January 2025. 104 Cover Page Interactive Data File (embedded within Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEUROONE MEDICAL TECHNOLOGIES CORPORATION Dated: January 10, 2025 By: /s/ David Rosa David Rosa Chief Executive Officer 2